The University of Chicago Header Logo

Connection

Richard Quigg to Disease Models, Animal

This is a "connection" page, showing publications Richard Quigg has written about Disease Models, Animal.
Connection Strength

1.300
  1. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest. 2009 May; 119(5):1264-74.
    View in: PubMed
    Score: 0.202
  2. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem Int. 2007 Jan; 50(1):5-11.
    View in: PubMed
    Score: 0.168
  3. Why study membranous nephropathy in rats? Kidney Int. 2003 Dec; 64(6):2318-9.
    View in: PubMed
    Score: 0.138
  4. A complement-dependent model of thrombotic thrombocytopenic purpura induced by antibodies reactive with endothelial cells. Clin Immunol. 2002 Apr; 103(1):43-53.
    View in: PubMed
    Score: 0.123
  5. Complement regulation in renal disease models. Semin Nephrol. 2013 Nov; 33(6):575-85.
    View in: PubMed
    Score: 0.069
  6. The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice. Kidney Int. 2012 Nov; 82(9):961-8.
    View in: PubMed
    Score: 0.063
  7. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
    View in: PubMed
    Score: 0.055
  8. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
    View in: PubMed
    Score: 0.053
  9. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab Invest. 2007 Apr; 87(4):357-64.
    View in: PubMed
    Score: 0.043
  10. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol. 2007 Mar; 18(3):811-22.
    View in: PubMed
    Score: 0.043
  11. Complement in lupus nephritis: the good, the bad, and the unknown. Semin Nephrol. 2007 Jan; 27(1):69-80.
    View in: PubMed
    Score: 0.043
  12. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy. Neurochem Int. 2005 Jul; 47(1-2):143-51.
    View in: PubMed
    Score: 0.039
  13. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta. 2003 Nov 20; 1639(3):169-76.
    View in: PubMed
    Score: 0.035
  14. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol. 2003 Mar; 14(3):670-9.
    View in: PubMed
    Score: 0.033
  15. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J Am Soc Nephrol. 2001 Jan; 12(1):71-79.
    View in: PubMed
    Score: 0.028
  16. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Renal Physiol. 2018 09 01; 315(3):F487-F502.
    View in: PubMed
    Score: 0.023
  17. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology. 2016 08; 148(4):407-19.
    View in: PubMed
    Score: 0.021
  18. Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells. Immunology. 2014 Nov; 143(3):363-73.
    View in: PubMed
    Score: 0.018
  19. Contrasting effects of systemic monocyte/macrophage and CD4+ T cell depletion in a reversible ureteral obstruction mouse model of chronic kidney disease. Clin Dev Immunol. 2013; 2013:836989.
    View in: PubMed
    Score: 0.017
  20. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus. Brain Res. 2013 Apr 04; 1504:85-96.
    View in: PubMed
    Score: 0.016
  21. Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. Am J Physiol Renal Physiol. 2012 Jun 15; 302(12):F1529-36.
    View in: PubMed
    Score: 0.015
  22. Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol. 2010 Apr 15; 221(1-2):46-52.
    View in: PubMed
    Score: 0.013
  23. NF-kappaB-dependent genes induced by proteinuria and identified using DNA microarrays. Clin Exp Nephrol. 2008 Jun; 12(3):181-8.
    View in: PubMed
    Score: 0.012
  24. New approaches to the treatment of dense deposit disease. J Am Soc Nephrol. 2007 Sep; 18(9):2447-56.
    View in: PubMed
    Score: 0.011
  25. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol. 2005 May 01; 174(9):5750-7.
    View in: PubMed
    Score: 0.010
  26. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10837-42.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.